DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS (Q2035310)

From EU Knowledge Graph
Revision as of 15:21, 23 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q2035310 in Italy
Language Label Description Also known as
English
DECISION SUPPORT SYSTEM (DSS) FOR MOLECULAR RADIOTHERAPY BASED ON DIGITAL PATIENTS
Project Q2035310 in Italy

    Statements

    0 references
    183,393.18 Euro
    0 references
    366,786.35 Euro
    0 references
    50.0 percent
    0 references
    13 December 2016
    0 references
    6 July 2019
    0 references
    UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
    0 references
    KAY SYSTEMS ITALIA SRL
    0 references
    0 references
    0 references
    0 references

    41°53'35.95"N, 12°28'58.55"E
    0 references
    LA RADIOTERAPIA MOLECOLARE, INDICATA IN MOLTE NEOPLASIE, IMPIEGA RADIONUCLIDI COME SORGENTI NON SIGILLATE (SPESSO RADIOFARMACI) PER RILASCIARE RADIAZIONI E DISTRUGGERE CELLULE NEOPLASTICHE. (Italian)
    0 references
    THE MOLECULAR RADIOTHERAPY, REFERRED TO IN MANY CANCERS, USES RADIONUCLIDES AS NON-SEALED SOURCES (OFTEN RADIOPHARMACEUTICALS) TO RELEASE RADIATION AND DESTROY NEOPLASTIC CELLS. (English)
    0 references
    LA RADIOTHÉRAPIE MOLÉCULAIRE, INDIQUÉE DANS DE NOMBREUX NÉOPLASMES, UTILISE LES RADIONUCLÉIDES COMME SOURCES NON SCELLÉES (SOUVENT RADIOPHARMACEUTIQUES) POUR LIBÉRER LE RAYONNEMENT ET DÉTRUIRE LES CELLULES NÉOPLASIQUES. (French)
    16 December 2021
    0 references
    MOLECULAIRE RADIOTHERAPIE, GEÏNDICEERD IN VEEL NEOPLASMA’S, GEBRUIKT RADIONUCLIDEN ALS NIET-VERZEGELDE BRONNEN (VAAK RADIOFARMACEUTICA) OM STRALING VRIJ TE GEVEN EN NEOPLASTISCHE CELLEN TE VERNIETIGEN. (Dutch)
    23 December 2021
    0 references

    Identifiers

    F87H18000440007
    0 references